Net Medical Xpress Solutions, Inc. (NMXS)
USD 0.01
(-3.61%)
USD 0.01
(-3.61%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -60 Thousand USD | -101.89% |
| 2022 | 3.18 Million USD | 368.34% |
| 2021 | 679 Thousand USD | 232.84% |
| 2020 | 204 Thousand USD | -40.7% |
| 2019 | 344 Thousand USD | -38.57% |
| 2018 | 560 Thousand USD | -40.36% |
| 2017 | 939 Thousand USD | 21.79% |
| 2016 | 771 Thousand USD | -33.93% |
| 2015 | 1.16 Million USD | 42.67% |
| 2014 | 818 Thousand USD | -29.54% |
| 2013 | 1.16 Million USD | 25.79% |
| 2012 | 923 Thousand USD | 36.14% |
| 2011 | 678 Thousand USD | -16.81% |
| 2010 | 815 Thousand USD | -13.94% |
| 2009 | 947 Thousand USD | 104.54% |
| 2008 | 463 Thousand USD | -9.57% |
| 2007 | 512 Thousand USD | 14.8% |
| 2006 | 446 Thousand USD | -45.34% |
| 2005 | 816 Thousand USD | 26.71% |
| 2004 | 644 Thousand USD | -33.61% |
| 2003 | 970 Thousand USD | -14.24% |
| 2002 | 1.13 Million USD | 42.8% |
| 2001 | 792 Thousand USD | 57.77% |
| 2000 | 502 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -52 Thousand USD | -57.58% |
| 2023 Q2 | -18 Thousand USD | -100.0% |
| 2023 Q1 | -9000.00 USD | -103.57% |
| 2023 FY | -60 Thousand USD | -101.89% |
| 2023 Q4 | -33 Thousand USD | -3200.0% |
| 2023 Q3 | -1000.00 USD | 94.44% |
| 2022 Q2 | 947 Thousand USD | -28.8% |
| 2022 FY | 3.18 Million USD | 368.34% |
| 2022 Q3 | 540 Thousand USD | -42.98% |
| 2022 Q1 | 1.33 Million USD | 182.38% |
| 2022 Q4 | 252 Thousand USD | -53.33% |
| 2021 Q4 | 471 Thousand USD | 582.61% |
| 2021 Q1 | 73 Thousand USD | 0.0% |
| 2021 Q2 | 65 Thousand USD | -10.96% |
| 2021 FY | 679 Thousand USD | 232.84% |
| 2021 Q3 | 69 Thousand USD | 6.15% |
| 2020 FY | 204 Thousand USD | -40.7% |
| 2019 FY | 344 Thousand USD | -38.57% |
| 2018 Q2 | 166 Thousand USD | 78.49% |
| 2018 FY | 560 Thousand USD | -40.36% |
| 2018 Q1 | 93 Thousand USD | 0.0% |
| 2017 Q3 | 156 Thousand USD | -9.83% |
| 2017 FY | 939 Thousand USD | 21.79% |
| 2017 Q2 | 173 Thousand USD | -8.47% |
| 2017 Q1 | 189 Thousand USD | 10.53% |
| 2016 Q3 | 127 Thousand USD | -30.98% |
| 2016 Q1 | 289 Thousand USD | 42.36% |
| 2016 Q4 | 171 Thousand USD | 34.65% |
| 2016 Q2 | 184 Thousand USD | -36.33% |
| 2016 FY | 771 Thousand USD | -33.93% |
| 2015 Q4 | 203 Thousand USD | -44.84% |
| 2015 Q3 | 368 Thousand USD | 32.37% |
| 2015 FY | 1.16 Million USD | 42.67% |
| 2015 Q2 | 278 Thousand USD | -12.3% |
| 2015 Q1 | 317 Thousand USD | 109.93% |
| 2014 FY | 818 Thousand USD | -29.54% |
| 2014 Q2 | 215 Thousand USD | -25.61% |
| 2014 Q1 | 289 Thousand USD | 12.45% |
| 2014 Q4 | 151 Thousand USD | -7.36% |
| 2014 Q3 | 163 Thousand USD | -24.19% |
| 2013 Q1 | 305 Thousand USD | 15.97% |
| 2013 Q2 | 279 Thousand USD | -8.52% |
| 2013 FY | 1.16 Million USD | 25.79% |
| 2013 Q4 | 257 Thousand USD | -19.69% |
| 2013 Q3 | 320 Thousand USD | 14.7% |
| 2012 Q2 | 217 Thousand USD | 5.34% |
| 2012 Q1 | 206 Thousand USD | 34.64% |
| 2012 FY | 923 Thousand USD | 36.14% |
| 2012 Q4 | 263 Thousand USD | 10.97% |
| 2012 Q3 | 237 Thousand USD | 9.22% |
| 2011 Q3 | 152 Thousand USD | 15.15% |
| 2011 Q2 | 132 Thousand USD | -45.0% |
| 2011 Q1 | 240 Thousand USD | 31.15% |
| 2011 FY | 678 Thousand USD | -16.81% |
| 2011 Q4 | 153 Thousand USD | 0.66% |
| 2010 Q2 | 166 Thousand USD | -29.06% |
| 2010 Q4 | 183 Thousand USD | -21.12% |
| 2010 Q3 | 232 Thousand USD | 39.76% |
| 2010 Q1 | 234 Thousand USD | 8.33% |
| 2010 FY | 815 Thousand USD | -13.94% |
| 2009 Q3 | 238 Thousand USD | 5.31% |
| 2009 FY | 947 Thousand USD | 104.54% |
| 2009 Q2 | 226 Thousand USD | -12.74% |
| 2009 Q4 | 216 Thousand USD | -9.24% |
| 2009 Q1 | 259 Thousand USD | 159.0% |
| 2008 FY | 463 Thousand USD | -9.57% |
| 2008 Q3 | 136 Thousand USD | 115.87% |
| 2008 Q2 | 63 Thousand USD | -60.87% |
| 2008 Q1 | 161 Thousand USD | 151.56% |
| 2008 Q4 | 100 Thousand USD | -26.47% |
| 2007 FY | 512 Thousand USD | 14.8% |
| 2007 Q4 | 64 Thousand USD | -45.76% |
| 2007 Q3 | 118 Thousand USD | -27.61% |
| 2007 Q2 | 163 Thousand USD | -2.4% |
| 2007 Q1 | 167 Thousand USD | 24.63% |
| 2006 Q1 | 97 Thousand USD | 585.0% |
| 2006 FY | 446 Thousand USD | -45.34% |
| 2006 Q4 | 134 Thousand USD | 45.65% |
| 2006 Q3 | 92 Thousand USD | -24.59% |
| 2006 Q2 | 122 Thousand USD | 25.77% |
| 2005 Q3 | 458 Thousand USD | 917.78% |
| 2005 Q4 | -20 Thousand USD | -104.37% |
| 2005 Q2 | 45 Thousand USD | -86.49% |
| 2005 Q1 | 333 Thousand USD | 1210.0% |
| 2005 FY | 816 Thousand USD | 26.71% |
| 2004 FY | 644 Thousand USD | -33.61% |
| 2004 Q2 | 319 Thousand USD | 13.12% |
| 2004 Q3 | 72 Thousand USD | -77.43% |
| 2004 Q4 | -30 Thousand USD | -141.67% |
| 2004 Q1 | 282 Thousand USD | 33.65% |
| 2003 Q2 | 119 Thousand USD | -65.31% |
| 2003 Q1 | 343 Thousand USD | 419.7% |
| 2003 Q3 | 297 Thousand USD | 149.58% |
| 2003 FY | 970 Thousand USD | -14.24% |
| 2003 Q4 | 211 Thousand USD | -28.96% |
| 2002 Q3 | 31 Thousand USD | -95.28% |
| 2002 Q1 | 358 Thousand USD | 38.76% |
| 2002 FY | 1.13 Million USD | 42.8% |
| 2002 Q4 | 66 Thousand USD | 112.9% |
| 2002 Q2 | 657 Thousand USD | 83.52% |
| 2001 Q3 | 231 Thousand USD | 59.31% |
| 2001 Q4 | 258 Thousand USD | 11.69% |
| 2001 FY | 792 Thousand USD | 57.77% |
| 2001 Q1 | 158 Thousand USD | 0.0% |
| 2001 Q2 | 145 Thousand USD | -8.23% |
| 2000 FY | 502 Thousand USD | 0.0% |
| 2000 Q1 | 27 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Achiko AG | 23.34 Thousand USD | 357.014% |
| Accelera Innovations, Inc | - USD | Infinity% |
| Aspyra Inc. | 3.91 Million USD | 101.532% |
| Cannabis Sativa, Inc. | 773.08 Thousand USD | 107.761% |
| CompuMed, Inc. | 2.88 Million USD | 102.079% |
| CompuGroup Medical SE & Co. KGaA | 413.14 Million USD | 100.015% |
| Cogstate Limited | 24.7 Million USD | 100.243% |
| CareView Communications, Inc. | 6.53 Million USD | 100.919% |
| Craneware plc | 162.19 Million USD | 100.037% |
| Caduceus Software Systems Corp. | 925.07 Thousand USD | 106.486% |
| Certive Solutions Inc. | 137.87 Thousand USD | 143.518% |
| Drug Free Solution, Inc. | 805.00 USD | 7553.416% |
| DATATRAK International, Inc. | 5.14 Million USD | 101.166% |
| Strainsforpains, Inc. | 84.11 Thousand USD | 171.33% |
| Healixa Inc. | 210.81 Thousand USD | 128.462% |
| Easy Technologies Inc. | - USD | Infinity% |
| eWellness Healthcare Corporation | - USD | Infinity% |
| Founders Bay Holdings | 12.3 Million USD | 100.488% |
| Health Discovery Corporation | - USD | Infinity% |
| Healthcare Integrated Technologies, Inc. | 82.05 Thousand USD | 173.124% |
| H-Source Holdings Ltd. | - USD | Infinity% |
| InterCare DX, Inc. | -298.05 USD | -20030.851% |
| IQ-AI Limited | 614.03 Thousand USD | 109.771% |
| Cannabiz Mobile, Inc. | - USD | Infinity% |
| Mednow Inc. | -858.82 Thousand USD | 93.014% |
| Galileo Life Sciences, Inc. | - USD | Infinity% |
| MediXall Group, Inc. | -3.13 Million USD | 98.089% |
| Mitesco, Inc. | - USD | Infinity% |
| MobileSmith, Inc. | 821.2 Thousand USD | 107.306% |
| NantHealth, Inc. | 38.16 Million USD | 100.157% |
| OneLife Technologies Corp. | - USD | Infinity% |
| ORHub, Inc. | 222.9 Thousand USD | 126.918% |
| Patient Access Solutions, Inc. | 212.73 Thousand USD | 128.204% |
| Pharma-Bio Serv, Inc. | 5.06 Million USD | 101.184% |
| PPJ Healthcare Enterprises, Inc. | 216.06 Thousand USD | 127.769% |
| Medical Cannabis Payment Solutions, Inc. | -21.91 Thousand USD | -173.76% |
| Renalytix Plc | 156 Thousand USD | 138.462% |
| Revium Recovery Inc. | -2000.00 USD | -2900.0% |
| RYAH Group, Inc. | - USD | Infinity% |
| Carepay Inc. | 396.65 Thousand USD | 115.127% |
| Vaso Corporation | 50.59 Million USD | 100.119% |
| Vynleads, Inc. | -35.57 Thousand USD | -68.681% |